Table 3.
Case summaries of pregnant women with a serologic evidence of an acute RSV infection.
| Variables | Case 9 | Case 10 | Case 11 |
|---|---|---|---|
| Age [years] | 30 | 28 | 23 |
| Gestation [weeks] | 27 | 16 | 33 |
| Comorbidity/Risk Factors | Gestational diabetes | NR | NR |
| First Enrollment | |||
| Serum Collected [CDC week] | 44 | 48 | 45 |
| Time Post-Onset [days] | 4 | 5 | 2 |
| Virus | HRV | Negative | Negative |
| Neutralizing Antibodies RSV/A, RSV/B [titer] | 64, 181 | 512, 45 | 362, 90 |
| PLA concentration [μg/mL] | 0.9 | 18.8 | 3.3 |
| Symptoms | Congestion Cough Sore throat Sneezing |
Congestion Sore throat Sneezing |
Congestion Cough Sore throat Decreased activity Short of breath Wheezing |
| Duration [days] | Still reporting at two weeks follow-up | Still reporting at two weeks follow-up | Still reporting at two weeks follow-up |
| Second Enrollment | |||
| Serum Collected [CDC week] | 46 | 1 | 52 |
| Time Post-Onset [days] | 4 | 4 | NA |
| Virus | HCoV | Negative | Negative |
| Neutralizing Antibodies RSV/A, RSV/B [titer] | 128, 128 | 362, 45 | 256, 64 |
| PLA concentration [μg/mL] | 8.5 | 5.4 | 4.4 |
| Symptoms | Congestion Cough Sneezing Decreased activity Wheezing |
Congestion Cough Sore throat Decreased appetite Chest pain Wheezing |
NA |
| Duration [days] | 5 | Still reporting at two weeks follow-up | NA |
RSV, respiratory syncytial virus.
HRV, human rhinovirus.
PLA, palivizumab-like antibodies.
HCoV, human coronavirus.
NR, none reported.
NA, as this patient was enrolled as healthy, variables referring to illness are not applicable.